Sign in to view content

Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial

Roger A. Goldberg, MD, MBA

Video
Published 2018

Related

Applying the DRCR.net Anti-VEGF Treatment Algorithm for Proliferative Diabetic Retinopathy: Neovascular Outcomes Over 2 Years
Christina Joy Flaxel, MD
Annual Meeting Talks
2018
Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2022

Category: Imaging – Digital-Fluorescein angiography

See more